Skip to content

A Randomized Controlled Trial for Acupuncture in the treatment of Primary Fibromyalgia

A Randomized Controlled Trial for Acupuncture in the treatment of Primary Fibromyalgia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016826
Enrollment
Unknown
Registered
2018-06-27
Start date
2018-07-01
Completion date
Unknown
Last updated
2018-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Interventions

acupuncture group:Acupuncture
Sham Acupuncture group:Sham Acupuncture

Sponsors

Guang'an Men hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged at least 18 years; 2. To meet the American College of Rheumatology Criteria for primary FM; 3. Without any contraindications for acupuncture; 4. Without taking FM medicines, or have not been taking FM medicines for at least 2 weeks before the recruitment.

Exclusion criteria

Exclusion criteria: 1. Have been having serious systemic disorders recently (lymphoma; central nervous system, renal, or pulmonary involvement; myositis; or vasculitis) or severe renal or liver failure; 2. With systemic or local acute infection; 3. Secondary FM; 4. Pain VAS under 4.0/10.0cm; 5. Currently or planning to be pregnant.

Design outcomes

Primary

MeasureTime frame
The change of Visual Analogue Scales for pain (PVAS) from baseline to 8 weeks;The change of Fibromyalgia Impact Questionnaire (FIQ) from baseline to 8 weeks;

Secondary

MeasureTime frame
The change of Multidimensional Assessment Fatigue (MAF) from baseline to 8 weeks;The change of the Short Form-36 Health Status Questionnaire (SF-36) from baseline to 8 weeks;The change of Pittsburgh sleep quality index (PSQI) from baseline to 8 weeks;The change of Beck depression inventory (BDI) from baseline to 8 weeks;The change of Perceived Stress Scale (PSS) from baseline to 8 weeks;

Countries

China

Contacts

Public ContactMAN HAN

Guang'an Men hospital, China Academy of Chinese Medical Sciences

hanman111@126.com+86 15011565229

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026